| 1 |
32860733 | Multi-site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos. | 2021 Jan |
1 |
| 2 |
34457036 | Influence of NQO1 Polymorphisms on Warfarin Maintenance Dose: A Systematic Review and Meta-Analysis (rs1800566 and rs10517). | 2021 |
7 |
| 3 |
29776386 | Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation. | 2018 May 18 |
3 |
| 4 |
27581200 | Gene polymorphisms and the risk of warfarin-induced bleeding complications at therapeutic international normalized ratio (INR). | 2016 Oct 15 |
1 |
| 5 |
28210634 | Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient: Role of a Novel NQO1*2 Polymorphism. | 2016 Oct-Dec |
3 |
| 6 |
26257249 | Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves. | 2015 Oct |
4 |
| 7 |
23215885 | Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans. | 2012 Dec |
5 |
| 8 |
18034618 | Factors influencing warfarin dose requirements in African-Americans. | 2007 Nov |
1 |
| 9 |
2113031 | Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition. | 1990 |
1 |